Clinical Trial Update: Effect of the Known Antihypertensive Drug Telmisartan on Red Blood Cells and Circulation in the Smallest Blood Vessels [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the effect of telmisartan on red blood cells and microcirculation in small vessels was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arterial Hypertension
• Type 2 Diabetes Mellitus

Drugs mentioned

• Telmisartan (Telmisartan)

Snippet

Sponsor: RWTH Aachen University | Conditions: Arterial Hypertension, Diabetes Mellitus Type 2 IRC or NIR | Phase 4 | Status: TERMINATED